Pricing Log in Create free account

Alpha Cognition Inc. (ACOG) vs Bicycle Therapeutics PLC Sponsored ADR (BCYC)

Alpha Cognition Inc. and Bicycle Therapeutics PLC Sponsored ADR are both Biotechnology companies. Alpha Cognition Inc. and Bicycle Therapeutics PLC Sponsored ADR are of similar size ($184.0M and $181.4M). Alpha Cognition Inc. has the higher net margin (−137.7% vs −311.1%) and the higher return on invested capital (−144.7% vs −64,747.5%). Across the 15 metrics below, Bicycle Therapeutics PLC Sponsored ADR leads on 8 and Alpha Cognition Inc. on 7.

Valuation

Metric ACOG BCYC Biotechnology median
P/E n/m n/m 8.50
P/S 11.69 3.95 9.71
P/B 3.37 0.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.21 0.64
EV/Sales 9.04 (4.04) 9.21
Earnings yield (13.19%) (78.90%) (33.15%)
Free cash flow yield (20.79%) (86.23%) (25.50%)

Profitability

Metric ACOG BCYC Biotechnology median
Gross margin 90.37% 100.00% 65.16%
Operating margin (174.70%) (343.60%) 0.00%
Net margin (137.69%) (311.11%) 0.00%
Free cash flow margin (242.99%) (340.29%) 0.00%
Return on equity (49.53%) (32.30%) (56.36%)
Return on assets (38.33%) (26.47%) (48.04%)
Return on invested capital (144.65%) (64,747.54%) 0.00%

Growth

Metric ACOG BCYC Biotechnology median
Revenue growth (TTM) — 217.44% 6.02%
EPS growth (last fiscal year) 42.08% (8.97%) 30.26%
Revenue growth, 5-year CAGR — 47.52% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG BCYC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 12.08 4.72
Net debt to EBITDA 2.92 2.61 0.96

Dividend

Metric ACOG BCYC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACOG BCYC Biotechnology median
Market cap 184.02m 181.37m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack